Replies to post #163701 on Arrayit Corporation (ARYC)

[MikeCr]

The major source of their revenue now comes from the allergy test. They are on track for $100M billing for that test in 2019. 25% to 40% of that will become revenue for 2019.

And there is no FDA approval yet. Still waiting.